Errikos Petsas
Athens, ESYE31 15771, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting the Crosstalk Between Metabolism and Chronic Inflammation: In Silico Multitargeting Drug Design Approach for Cardiometabolic Syndrome.
Journal: Biomedicines
Published: May 03, 2026
Correction: Petsas et al. Protein-Ligand Interactions in Cardiometabolic Drug Targets: Focus on Weight Loss and Cardioprotection. Molecules 2025, 30, 4240.
Journal: Molecules (Basel, Switzerland)
Published: January 14, 2026
Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation".
Journal: Life (Basel, Switzerland)
Published: December 12, 2025
Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024).
Journal: Biomolecules
Published: November 02, 2025
Structure-Based Design and In Silico Evaluation of a Lipophilic Cyclooctanoyl- Derivative as a Renin Inhibitor: Lessons from Withdrawn Aliskiren.
Journal: International journal of molecular sciences
Published: October 22, 2025
Protein-Ligand Interactions in Cardiometabolic Drug Targets: Focus on Weight Loss and Cardioprotection.
Journal: Molecules (Basel, Switzerland)
Published: September 29, 2025
In silico and NMR studies on pharmaceutical compounds with therapeutic action against Myasthenia Gravis.
Journal: Journal of biomolecular structure & dynamics
Published: July 24, 2025
Quercetin: A Potential Polydynamic Drug.
Journal: Molecules (Basel, Switzerland)
Published: November 27, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026